Literature DB >> 15642262

A vinculin binding domain from the talin rod unfolds to form a complex with the vinculin head.

Ian Fillingham1, Alexandre R Gingras, Evangelos Papagrigoriou, Bipin Patel, Jonas Emsley, David R Critchley, Gordon C K Roberts, Igor L Barsukov.   

Abstract

The cytoskeletal protein talin plays a key role in activating integrins and in coupling them to the actin cytoskeleton. Its N-terminal globular head, which binds beta integrins, is linked to an extended rod having a C-terminal actin binding site and several vinculin binding sites (VBSs). The NMR structure of residues 755-889 of the rod (containing a VBS) is shown to be an amphipathic four-helix bundle with a left-handed topology. A talin peptide corresponding to the VBS binds the vinculin head; the X-ray crystallographic structure of this complex shows that the residues which interact with vinculin are buried in the hydrophobic core of the talin fragment. NMR shows that the interaction involves a major structural change in the talin fragment, including unfolding of one of its helices, making the VBS accessible to vinculin. Interestingly, the talin 755-889 fragment binds more than one vinculin head molecule, suggesting that the talin rod may contain additional as yet unrecognized VBSs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642262     DOI: 10.1016/j.str.2004.11.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  51 in total

1.  The cytoskeletal protein α-catenin unfurls upon binding to vinculin.

Authors:  Erumbi S Rangarajan; Tina Izard
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

2.  Subcellular localization of talin is regulated by inter-domain interactions.

Authors:  Asoka Banno; Benjamin T Goult; HoSup Lee; Neil Bate; David R Critchley; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2012-02-18       Impact factor: 5.157

3.  Crystal structure of vinculin in complex with vinculin binding site 50 (VBS50), the integrin binding site 2 (IBS2) of talin.

Authors:  S D Yogesha; Erumbi S Rangarajan; Clemens Vonrhein; Gerard Bricogne; Tina Izard
Journal:  Protein Sci       Date:  2012-02-28       Impact factor: 6.725

4.  Vinculin binding in its closed conformation by a helix addition mechanism.

Authors:  Guy Tran Van Nhieu; Tina Izard
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

5.  The talin rod IBS2 alpha-helix interacts with the beta3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges.

Authors:  Sophie Rodius; Olivier Chaloin; Michèle Moes; Elisabeth Schaffner-Reckinger; Isabelle Landrieu; Guy Lippens; Minghui Lin; Ji Zhang; Nelly Kieffer
Journal:  J Biol Chem       Date:  2008-06-23       Impact factor: 5.157

Review 6.  Structure and mechanics of integrin-based cell adhesion.

Authors:  M Amin Arnaout; Simon L Goodman; Jian-Ping Xiong
Journal:  Curr Opin Cell Biol       Date:  2007-10-24       Impact factor: 8.382

7.  Intermolecular versus intramolecular interactions of the vinculin binding site 33 of talin.

Authors:  S D Yogesha; A Sharff; G Bricogne; T Izard
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

8.  The structure of an interdomain complex that regulates talin activity.

Authors:  Benjamin T Goult; Neil Bate; Nicholas J Anthis; Kate L Wegener; Alexandre R Gingras; Bipin Patel; Igor L Barsukov; Iain D Campbell; Gordon C K Roberts; David R Critchley
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

Review 9.  Cell fate regulation by coupling mechanical cycles to biochemical signaling pathways.

Authors:  Viola Vogel; Michael P Sheetz
Journal:  Curr Opin Cell Biol       Date:  2009-02-11       Impact factor: 8.382

10.  Central region of talin has a unique fold that binds vinculin and actin.

Authors:  Alexandre R Gingras; Neil Bate; Benjamin T Goult; Bipin Patel; Petra M Kopp; Jonas Emsley; Igor L Barsukov; Gordon C K Roberts; David R Critchley
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.